CORE A - Optical mapping is a key methodology to be used throughout the program by all the projects. It will allow us to measure features of spinal cord injury-induced lower urinary tract pathology not obtainable by other approaches. These include functional measurement of neuropeptide release by afferent nerves, neural remodeling in the bladder and spinal cord and cell-cell interactions in bladder wall cross-sections and in-line primary cells. Therefore, the Imaging Core A, providing the support to set up and run experiments, will be central to the program. Co-directors of the core, Drs. Kanai and Salama, are experts in optical mapping using voltage- and Ca2+-sensitive dyes with a broad experience in application of this technique to study visceral organs, especially urinary bladder. They will provide three fully functional dual-imaging systems to measure voltage and Ca2+ signals from organs, tissues and cells in the bladder and spinal cord. Two of these are low resolution (256 pixels) fast acquisition (4000 frames/s) PDA systems that can record for minutes. The other is a high resolution (2.7 millon pixels) slow acquisition (540 frames/s) system that can record for seconds. The core will also offer commerically available as well as unique dyes (e.g., PGH-1 to PHG-Vl;developed by Drs. Guy Salama and Allen Waggoner) to measure membrane potential, intracellular Ca2+, K+ and nitric oxide, in vitro or in vivo. The core personnel will also offer expertise in dye delivery and acquisition using unique in-house software. This imaging apporach will utilize the genetically encoded Ca2+ indicator, GCaMP4, expressed through viral vectors, to selectively label sensory and motoneurons and their terminals. Thermoregulated ceramic chambers, custom-built by the core, will be available for recordings from the different preparations. Custom modifications to equipment and software will be provided as required. The core will coordinate the efficient use of imaging systems, assist with setting up experiments, analyzing data and troubleshooting. Imaging Core A will closely interact with Animal Core B for more efficient use of imaging systems and animals, taking into consideration the timepoints for treated animals and correlating them with the needs of individual projects.

Agency
National Institute of Health (NIH)
Type
Research Program Projects (P01)
Project #
5P01DK093424-02
Application #
8723177
Study Section
Special Emphasis Panel (ZDK1)
Project Start
Project End
Budget Start
Budget End
Support Year
2
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of Pittsburgh
Department
Type
DUNS #
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Tyagi, Pradeep; Kashyap, Mahendra; Yoshimura, Naoki et al. (2016) Past, Present, and Future of Chemodenervation With Botulinum Toxin in the Treatment of OAB. J Urol :
Kadekawa, Katsumi; Yoshimura, Naoki; Majima, Tsuyoshi et al. (2016) Characterization of bladder and external urethral activity in mice with or without spinal cord injury--a comparison study with rats. Am J Physiol Regul Integr Comp Physiol 310:R752-8
Tyagi, Pradeep; Kadekawa, Katsumi; Kashyap, Mahendra et al. (2016) Spontaneous Recovery of Reflex Voiding Following Spinal Cord Injury Mediated by Anti-inflammatory and Neuroprotective Factors. Urology 88:57-65
Yu, Yongbei; Daugherty, Stephanie L; de Groat, William C (2016) Effects of nicotinic receptor agonists on bladder afferent nerve activity in an in vitro bladder-pelvic nerve preparation. Brain Res 1637:91-101
Kashyap, Mahendra; Pore, Subrata; Yoshimura, Naoki et al. (2016) Constitutive expression Of NGF And P75(NTR) affected by bladder distension and NGF antisense treatment. Life Sci 148:93-8
Walker, K A; Ikeda, Y; Zabbarova, I et al. (2015) Fgfr2 is integral for bladder mesenchyme patterning and function. Am J Physiol Renal Physiol 308:F888-98
Sunagawa, Masataka; Wolf-Johnston, Amanda; Nomiya, Masanori et al. (2015) Urinary bladder mucosal responses to ischemia. World J Urol 33:275-80
Sugino, Yoshio; O'Malley, Katherine J; Wang, Zhou et al. (2015) Laser-capture microdissection for analysis of cell type-specific gene expression of muscarinic receptor subtypes in the rat bladder with cyclophosphamide-induced cystitis. Int Urol Nephrol 47:637-42
Ogawa, Teruyuki; Ishizuka, Osamu; Ueda, Tomohiro et al. (2015) Current and emerging drugs for interstitial cystitis/bladder pain syndrome (IC/BPS). Expert Opin Emerg Drugs 20:555-70
Yoshikawa, S; Kawamorita, N; Oguchi, T et al. (2015) Pelvic organ cross-sensitization to enhance bladder and urethral pain behaviors in rats with experimental colitis. Neuroscience 284:422-9

Showing the most recent 10 out of 18 publications